![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
FAP INHIBITORS: IN DIABETIC NEPHROPATHY?
Dr. Navneet Omprakash Soni*
ABSTRACT FAP inhibitor increases the endogenous level of FGF-21which may help in various Metabolic disease, Diabetes and Diabetic complication. Animal model have shown FGF-21 has protected renal damage in Diabetic animal model. However inhibition by FAP inhibitor and raised level of endogenous FGF-21,such raised endogenous FGF-21 have nephroprotective effect have not yet evaluated but FGF-21 mimetic drugs are in trial for Diabetes and metabolic disorder even FGF-21 MIMETICS are not evaluated for Diabetic nephropathy. Probable benefits of FAP inhibitors are highlighted based on evidence and study report. Keywords: FGF-21, CHD, FAP, FAP Inhibitor, Diabetic Nephropathy. [Download Article] [Download Certifiate] |